Geratal, September 18, 2024. The realignment of Geratherm Medical AG has begun. Geratherm Medical AG sells 100% of its 60.55% stake in apoplex medical technologies together with the other shareholders to a German-American consortium.

The transaction value amounts to around EUR 16.5 million. This is divided into EUR 8 million, which is due after the contract is signed, and an additional earn-out component, depending on the EBITDA results achieved over the next 4 years. The sale is expected to be closed by the end of October 2024.